Results 171 to 180 of about 21,178 (234)

Integrated Genetic and Protein Mechanisms Underlying Glucagon-like Peptide-1 Receptor Agonists in Treating Diabetes Mellitus and Weight Loss. [PDF]

Curr Issues Mol Biol
Francis L, Butler MG.
europepmc   +1 more source

Delayed gastric emptying induced by glucagon-like peptide-1 receptor agonists and its implications for perioperative risk during anesthesia. [PDF]

Korean J Intern Med
Kang D, Choi D.
europepmc   +1 more source

Acute onset of neovascular age-related macular degeneration after initiation of tirzepatide. [PDF]

Diabetol Int
Takebayashi K, Iemura Y, Yamauchi M, Hara K, Tsuchiya T, Machida S, Hashimoto K.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Glucose-dependent insulinotropic polypeptide/gastric inhibitory polypeptide

Best Practice and Research in Clinical Endocrinology and Metabolism, 2004
The 42 amino acid polypeptide glucose-dependent insulinotropic polypeptide/gastric inhibitory polypeptide (GIP) is released from intestinal K-cells in response to nutrient ingestion. Based on animal studies, the peptide was initially assumed to act as an endogenous inhibitor of gastric acid secretion.
Michael Albrecht Nauck, Juris Meier
exaly   +2 more sources

Transcriptional Analysis of Apoptotic Cerebellar Granule Neurons Following Rescue by Gastric Inhibitory Polypeptide [PDF]

International Journal of Molecular Sciences, 2014
Sebastiano Cavallaro, Pietro Calissano, Maria TERESA Ciotti   +2 more
exaly   +2 more sources

Gastric Inhibitory Polypeptide

Clinics in Gastroenterology, 1980
The available data show that GIP is at present the strongest candidate for the insulin-secreting factor of the gut named incretin. Its release is triggered by the absorption of ingested nutrients. GIP acts on the B-cells of the pancreas by potentiating glucose-induced insulin secretion. The role of GIP as an enterogastrone is less well established. The
R, Ebert, W, Creutzfeldt
openaire   +2 more sources

Gastric Inhibitory Polypeptide

Comprehensive Physiology, 1989
Abstract The sections in this article are: Gastric Inhibitory Effect of Gastric Inhibitory Polypeptide Insulinotropic Action of GIP
John C Brown, Alison M. J. Buchan, Christopher H. S. McIntosh, Raymond A. Pederson   +3 more
openaire   +1 more source

Clinical studies with gastric inhibitory polypeptide

World Journal of Surgery, 1979
AbstractIntravenous infusion of porcine GIP in man induces insulin release when a degree of hyperglycemia is present. This glucose‐dependent insulinotropic response occurs when a dose of GIP is administered to obtain circulating levels of approximately 1 ng/ml, a physiologic level that can be achieved by the ingestion of glucose or corn oil or a mixed ...
J C, Brown, S, Otte
openaire   +2 more sources